Raymond James had its Relative Strength (RS) Rating upgraded from 69 to 77 Monday — a welcome improvement, but still short of the 80 or better score you prefer to see.
IBD's proprietary RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the trailing 52 weeks matched up against all other stocks.
Decades of market research shows that the market's biggest winners typically have an 80 or higher RS Rating as they launch their largest price moves. See if Raymond James can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Raymond James is building a consolidation with a 174.32 entry. See if it can break out in volume at least 40% higher than normal.
While earnings-per-share growth declined in the company's most recent quarterly report from 38% to 22%, revenue rose 15%, up from 14% in the prior report. Keep an eye out for the company's next round of numbers on or around Apr. 23.
The company earns the No. 6 rank among its peers in the Finance-Investment Banking/Brokers industry group. Futu Holdings ADR, LPL Financial Holdings and StoneX Group are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
